The number 300,000 almost jumps out of the recent Associated Press story on the results of a study on the role a two-day biotech conference in Boston played in the COVID-19 pandemic. That’s the potential number of cases that can be traced from 29 states and overseas to that meeting last February of Biogen managers,
Already a Subscriber? Log in
To Continue Reading This Article
Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.Learn More and Become a Subscriber
